China reveals new team of astronauts for space station launch
BEIJING: China announced Wednesday the members of a three-person crew that will be launched to its space station as part of its growing exploration of space.
The
Shenzhou 20 mission
's astronauts are Chen Dong, Chen Zhongrui, and Wang Jie, Lin Xiqiang, deputy director general of China Manned Space Agency.
Tired of too many ads? go ad free now
They will replace three astronauts currently on the
Chinese space station
. Like those before them, they will stay there for roughly six months.
The three will launch for space Thursday evening in China, from Jiuquan, on the edge of the Gobi Desert in northwestern China. The three-person crew were sent in October last year and have been in space for 175 days, said Lin.
Chen Dong, who previously served on the Shenzhou 11 and Shenzhou 14 missions, is the group leader, while his two crewmates will be making their first trips to space.
Chen Zhongrui was an air force pilot and Wang Jie, an engineer with the China Aerospace Science and Technology Corporation.
"I feel incomparable pride and accomplishment to go to space for my country again," Chen Dong told reporters on Wednesday. "Each journey to space is unparalleled, I'm looking forward to gaining more experience and more breakthroughs through this flight."
Chen Dong led construction of the space station during the Shenzhou 14 mission.
While in space, the astronauts will carry out experiments in space medicine, and space technology; perform extravehicular trips; and make improvements to the space station.
China built its own space station after it was excluded from the International Space Station owing to US national security concerns over the control of the country's space program by the People's Liberation Army, the military branch of the ruling Communist Party.
Tired of too many ads? go ad free now
China's space program has grown rapidly in recent years. The space agency has landed an explorer on Mars and a rover on the far side of the moon. It aims to put a person on the moon before 2030. The returning astronauts are expected to land on April 29.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
9 hours ago
- Economic Times
AstraZeneca signs AI research deal with China's CSPC for chronic diseases
AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which would help the Anglo-Swedish drugmaker develop therapies for chronic conditions, it said on Friday. The deal marks the latest effort by AstraZeneca to revive its business in China, its second-biggest market, where it has faced several challenges including the arrest of its China president last year and potential fines related to imports. Under Friday's agreement, the two companies will collaborate to discover and develop pre-clinical candidates, including a small molecule oral therapy for immunological diseases, with CSPC conducting AI-driven research in Shijiazhuang City. "This strategic research collaboration underscores our commitment to innovation to tackle chronic diseases which impact over two billion people globally," AstraZeneca executive Sharon Barr said in a statement. Friday's agreement follows AstraZeneca's announcement in March that it will invest $2.5 billion in a R&D hub in Beijing, and it also marks further investment in AI following collaborations with Immunai, and Tempus AI. AstraZeneca will pay CSPC an upfront fee of $110 million. The Hong Kong-listed firm is also eligible to receive up to $1.62 billion for reaching development milestones and $3.6 billion linked to sales-related milestones, the groups said in separate statements. They signed a licensing deal last October in which AstraZeneca agreed to pay up to $1.92 billion to CSPC to develop a candidate which would boost its cardiovascular pipeline. AstraZeneca and CSPC both have wide-ranging pipeline portfolios, including cancer treatments and those targeting cardiovascular diseases. However, about 80% of CSPC's total revenue comes from its finished drug segment, according Morningstar analysts. The Chinese group said last month it was in negotiations with third parties on new licensing and collaboration. Friday's agreement also gives AstraZeneca the rights to exercise options for exclusive licenses for candidates identified as part of the collaboration.
Indian Express
16 hours ago
- Indian Express
Axiom-4 mission: Leak on ISS, not oxygen leak from launch vehicle behind indefinite delay
While problems in electricals, oxygen leak, and unfavourable weather conditions were initially behind the delays of Axiom-4 space mission, it was an issue related to pressurisation in one of the modules of the International Space Station (ISS) that has now led to the mission being delayed indefinitely. 'The revised launch schedule will be announced by Nasa and Axiom after the activities and technical reviews are satisfactorily completed,' the Indian Space Research Organisation (Isro) said in a statement. Indian astronaut Group Captain Shubhanshu Shukla is set to travel to space on board the Axiom-4 mission, making him the country's second astronaut in space and the first on the ISS. Shukla will spend nearly 14 days at the ISS, conducting science experiments. On Friday, Isro provided a timeline of what led to the delays. The launch was initially targeted for May 29 but was deferred due to an 'observation in the electrical harness' of the SpaceX Dragon spacecraft — the module where the crew is seated for their journey to the ISS. The launch was then pushed to June 8 and then again by another day due to the delay in preparedness of the SpaceX Falcon 9 launch vehicle. The space agency said the launch was again pushed for a day due to unfavourable weather conditions on the ascent path of the rocket. In parallel, when the engines were test-fired on ground on June 8, an oxygen leak was observed in addition to an anomaly in one of the actuators. 'Anticipating the quick resolution of LOX (liquid oxygen) leak issue, the launch was rescheduled to June 11, 2025,' the space agency said, adding that it had suggested that the repairs and replacements could be carried out without moving or disassembling the vehicle. The Indian space agency suggested a low temperature leak test — a test that could assess the integrity of the components at very low temperatures — to validate the performance before moving for the final launch. On June 11, however, Nasa informed that it was working with the Russian space agency to evaluate a 'new pressure signature' that could indicate a leak in the back section of one of Russian modules of the space station — ISS Zvezda. This comes after a recent repair effort. The leak in the Zvezda module was first detected in 2019 and the space agencies have been working for years trying to fix it. Now, cosmonauts on board the space station have conducted inspections of the pressurised interior surfaces of the module, sealed off some 'additional areas of interest', and measured the current leak rate. 'The segment now is holding pressure,' Nasa said in a statement. The Axiom-4 mission was postponed, nonetheless, to provide additional time to Nasa and Roscosmos to evaluate the situation and determine if any additional troubleshooting might be needed.
Time of India
18 hours ago
- Time of India
US says China's Huawei can't make more than 200,000 AI chips in 2025
WASHINGTON: China's Huawei Technologies is capable of producing no more than 200,000 advanced artificial intelligence chips in 2025, a top U.S. exports controls official told lawmakers on Thursday, warning that though the number is below the company's demand, China is quickly catching up to U.S. capabilities. Since 2019, a slew of U.S. export rules aimed at curbing China's technological and military advancements have limited access by Huawei and other Chinese firms to high-end U.S. chips and the equipment needed to produce them. The issue has become a flashpoint in U.S.-China relations. Facing those restrictions, Huawei aims to ship its Ascend 910C AI chips to Chinese customers as an alternative to those made by the United States' Nvidia , the global leader. "Our assessment is that Huawei Ascend chip production capacity for 2025 will be at or below 200,000 and we project that most or all of that will be delivered to companies within China," Jeffrey Kessler , Under Secretary of Commerce for Industry and Security at the Commerce Department, told a congressional hearing. Kessler said that the U.S. should not take comfort in the figure. "China is investing huge amounts to increase its AI chip production, as well as the capabilities of the chips that it produces. So, it's critical for us not to have a false sense of security, to understand that China is catching up quickly," he told the House of Representatives Foreign Affairs South and Central Asia subcommittee. White House AI Czar David Sacks said on Tuesday that China was only 3-6 months behind the U.S. in AI. The White House later said he was referring to China's AI models, adding that Chinese AI chips are one to two years behind their U.S. counterparts. Huawei's CEO Ren Zhengfei told Chinese state media on Tuesday that the company's chips were a generation behind those of U.S. competitors, but that it invests more than $25 billion annually to improve performance. Nvidia's AI chips are more powerful than Huawei's but Washington's export controls on its most sophisticated chips have caused it to lose market share. The U.S. and China reached a tentative trade truce at talks in London this week after a previous agreement faltered over China's continued curbs on minerals exports. That prompted the Trump administration to apply additional export controls on shipments of semiconductor design software, jet engines for Chinese-made planes and other goods. Democratic Representative Greg Meeks expressed concern that the Trump administration had conflated U.S. exports controls with broader discussions on trade. "What I will say is export controls have been strong and I'm confident that they will remain strong," Kessler said. Kessler said he was not planning any immediate new restrictions on U.S. semiconductors sold to China, but that the Commerce Department will "remain active in this space." "It's a constantly evolving landscape, and we need to make sure that our controls remain effective," he said.
